Report cover image

Global Sciatica Treatment Market Growth, Size, Trends Analysis - By Type, By Drug Class, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jul 10, 2025
Length 275 Pages
SKU # SPER20337444

Description

Sciatica Treatment Market Introduction and Overview

According to SPER Market Research, ‘Global Sciatica Treatment Market Size- By Type, By Drug Class, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Sciatica Treatment Market is predicted to reach 11.85 billion by 2034 with a CAGR of 8.56%.

Sciatica mostly affects the sciatic nerves, which are the nerves that run down each leg from the lower back to the hips and buttocks. Sciatica can be acute, chronic, or other. Non-steroidal anti-inflammatory drugs (NSAIDs), steroids, antidepressants, and other medications are utilised for treatment, and they are mostly delivered through hospital pharmacies, retail and speciality pharmacies, and online providers.

Restraints:The high expense of sophisticated sciatica treatments and therapies creates a significant barrier to access for many people, highlighting a larger issue in healthcare economics. Sciatica, which is characterised by excruciating pain radiating along the sciatic nerve, frequently necessitates a variety of therapies, ranging from conservative measures like physical therapy to more intrusive techniques such as surgery.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Type, By Drug Class, By Distribution Channel

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Abbott Laboratories, Amneal Pharmaceuticals LLC, Bayer AG, Bristol Myers Squibb, Eliem Therapeutics, Novartis AG, Pfizer Inc, Scilex Holding, Sinfonia Biotherapeutics, Sorrento Therapeutics.Global Sciatica Treatment Market Segmentation:

By Type: Based on the Type, Global Sciatica Treatment Market is segmented as; Acute, Chronic.

By Drug Class: Based on the Drug Class, Global Sciatica Treatment Market is segmented as; Steroids, Antidepressants, Corticosteroids, NSAIDs.

By Distribution Channel: Based on the Distribution Channel, Global Sciatica Treatment Market is segmented as; Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

275 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Sciatica Treatment Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Sciatica Treatment Market
7. Global Sciatica Treatment Market, By Type (USD Million) 2021-2034
7.1. Acute
7.2. Chronic
8. Global Sciatica Treatment Market, By Drug Class (USD Million) 2021-2034
8.1. Steroids
8.2. Antidepressants
8.3. Corticosteroids
8.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
8.5. Other drug classes
9. Global Sciatica Treatment Market, By Distribution Channel (USD Million) 2021-2034
9.1. Hospital pharmacies
9.2. Retail pharmacies
9.3. Online pharmacies
10. Global Sciatica Treatment Market, (USD Million) 2021-2034
10.1. Global Sciatica Treatment Market Size and Market Share
11. Global Sciatica Treatment Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Amneal Pharmaceuticals LLC
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Bayer AG
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Bristol Myers Squibb
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Eliem Therapeutics
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Novartis AG
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Pfizer Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Scilex Holding
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Sinfonia Biotherapeutics
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sorrento Therapeutics
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.